Max Robotics — Global Service Robot Directory + US Certification

About

Beatriz E. Amendola is a pioneering radiation oncologist whose research has fundamentally advanced the use of stereotactic radiosurgery for treating lung cancer. Her work centers on image-guided robotic stereotactic radiosurgery, specifically utilizing the CyberKnife system to deliver precise, high-dose radiation to tumors while sparing healthy tissue. Amendola’s major contributions include demonstrating that CyberKnife radiosurgery achieves excellent local control in medically inoperable patients with early-stage non-small cell lung cancer and pulmonary metastases. Her landmark 2007 study, “CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months,” has garnered 86 citations, establishing a critical evidence base for non-surgical treatment of lung tumors. She further expanded this work in a 2008 study on lung metastases treated with CyberKnife, which has been cited 55 times, showing durable tumor control with minimal toxicity. Amendola’s research has been instrumental in transforming stereotactic body radiotherapy from an experimental approach into a standard-of-care option for patients who cannot undergo surgery. Her findings on local control rates and safety profiles have directly influenced clinical guidelines, making her a key figure in the evolution of non-invasive cancer treatment.